Open thoracotomy and decortication for chronic empyema thoracis: Our experience
https://doi.org/10.4081/cdr.10.9844
Accepted: 17 September 2021
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Empyema thoracis is defined as the presence of pus in the pleural space or a purulent pleural effusion. Chronic empyema is characterized by thickened visceral and parietal peels, which hamper the ability of the affected lung to re-expand and require definitive surgical intervention. In a resource constraint environment like ours, open thoracotomy and decortication is the treatment of choice. We review our experience with cases of chronic empyema thoracis that had thoracotomy and decortication. This is a descriptive, retrospective, and observational study. Medical records of patients who had thoracotomy and decortication on account of chronic empyema thoracis in the Cardiothoracic surgery unit of our hospital between 2012 and 2020 were retrieved and reviewed. The information obtained from the records included sex, age, premorbid conditions, aetiology of empyema, cultures of pleural fluids, histology results of the cortex removed, duration of chest tube drainage, duration of hospital stay, postoperative complications, and outcome. One hundred and eighty-five patients diagnosed with empyema thoracis were seen in the study period. Sixty-five patients had thoracotomy and decortication on account of chronic empyema thoracis while the remaining 120 (64.9%) had closed tube thoracostomy drain insertion. Male: female was 5:1, mean age at presentation 24.24 years with age ranging from 2 years to 70 years. Fourteen (23.33%) were in the paediatric age group while the remaining (76.67%) were adults. The aetiology of empyema was pneumonia in 36 (60%). Strept pneumoniae was the commonest organism isolated from pleural fluids of these patients accounting for 23.33%. All patients underwent thoracotomy and decortication. The mean duration before surgery was 17 days with a range of 2 days to 40 days. The average duration of surgery was 2 hours. Chest tube was removed after an average of 7 days (range 5 to 33 days. Twenty-one patients (35%) had complications. The average duration of drainage was 18.87 days and that of hospital stay was 36.74 days. There were 3 mortalities (5%). The mean duration of follow-up was 3 months. Chronic empyema thoracis is still common in our environment and presentation is usually very late. In our series, open thoracotomy and decortication was found to be an excellent procedure with low morbidity and mortality. The majority of our patients had good functional outcome with few complications.
Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006;3:75-80.
Mandal AK, Thadepalli H, Mandal AK, Chettipally U. Outcome of primary empyema thoracis: therapeutic and microbiologic aspects. Ann Thorac Surg 1998;66:1782–6.
Edaigbini S, Anumenechi N, Odigie V, et al. Open drainage for chronic empyema thoracis; clarifying misconceptions by report of two cases and review of literature. Arch Int Surg 2013;3:161.
Biswas A, Jantz MA, Penley AM, Mehta HJ. Management of chronic empyema with unexpandable lung in poor surgical risk patients using an empyema tube. Lung India 2016;33:267-71.
Jha VK, Singh RB: Empyema of the thorax. Indian J Chest Dis 1972:14:243-8.
Jadczuk E. Posptneumonectomy empyema. Eur J Cardiothorac Surg 1998;14:123–6.
Kacprzak G, Marciniak M, Addae-Boateng E, et al. Causes and management of postpneumonectomy empyemas: our experi-ence. Eur J Cardiothorac Surg 2004;26:498–502.
Sahn S. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993;148:813—7.
Waller DA, Rengarajan A. Thoracoscopic decortication: a role for video-assisted surgery in chronic postpneumonic pleural empyema. Ann Thorac Surg 2001;71:1813—6.
Davies HE, Davies RJO, Davies CWH. On behalf of the BTS pleural disease guideline group. Management of pleural infection in adults. British Thoracic Society Pleural Disease guideline 2010. Thorax 2010;65:ii41-ii53.
Fraga JC, Kim P. Surgical treatment of parapneumonic plearl effusion and its complications. J Pediatr 2002;78:161–73.
Balfour-Lynn IM, Abrahamson E, Cohen G, et al. On behalf of the paediatric pleural diseases subcommittee of the BTS standards of care committee. BTS guidelines for the management of pleural infection in children. Thorax 2005;60:i1–i2.
Luh SP, Chou MC, Wang LS, et al. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas. Chest 2005;127:1427-32.
Soriano T, Alegre J, Alemán C, et al. Factors influencing length of hospital stay in patients with bacterial pleural effusion. Respiration 2005;72:587-93.
Okiror L, Coltart C, Bille A, et al. Thoracotomy and decortication: impact of culture-positive empyema on the outcome of surgery. Eur J Cardio-Thoracic Surg 2014;46:901–6.
Biswas A, Jantz MA, Penley AM, Mehta HJ. Management of chronic empyema with unexpandable lung in poor surgical risk patients using an empyema tube. Lung India 2016;33:267-71.
Arnold FW, LaJoie AS, Brock GN, et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med 2009;169:1515–24.
Schweigert M, Solymosi N, Dubecz A, et al. Surgical management of pleural empyema in the very elderly. Ann R Coll Surg Engl 2012;94:331-5.
Tantraworasin A, Thepbunchonchai A, Siwachat S, et al. Factors associated with recurrent bacterial empyema thoracis. Asian Journal of Surgery (2018) 41, 313e320
Marks DJ, Fisk MD, Koo CY, et al. Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre. PLoS ONE 2012;7:e30074.
Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000;118:1158–71.
Hassan M, Cargill T, Harriss E, et al. The microbiology of pleural infection in adults: a systematic review. Eur Respir J 2019;54:1900542.
Gurney JW, Conces DJ Jr. Pulmonary histoplasmosis. Radiology 1996;199:297-306.
Goodwin RA Jr., Owens FT, Snell JD, Hubbard WW, et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1976;55:413-52.
Davis A, Pierson D, Loyd JE. Mediastinal fibrosis. Semin Respir Infect 2001;16:119-30.
Kauffman CA, Israel KS, Smith JW, et al. Histoplasmosis in immunosuppressed patients. Am J Med 1978;64:923-32.
Aregbeshola BS, Khan SM. Out-of-pocket payments, catastrophic health expenditure and poverty among households in Nigeria 2010. Int J Health Policy Manag 2018;7:798–806.
Goyal V, Kumar A, Gupta M, et al. Empyema thoracis in children: Still a challenge in developing countries. Afr J Paediatr Surg 2014;11:206-10.
Andrade-Alegre R, Garisto JD, Zebede S. Open thoracotomy and decortication for chronic empyema. Clinics 2008;63:789-93.
Carey JA, Hamilton JRL, Spencer DA, et al. Empyema thoracis: a role for open thoracotomy and decortication. Arch Dis Child 1998;79:510–3.
Mohapatra B, Sivakumar P, Khan MS. Role of decortication in management of parapneumonic empyema thoracis in children. Indian J Thorac Cardiovasc Surg 2013;29:235–40.
Molnar TF. Current surgical treatment of thoracic empyema in adults. Eur J Cardiothorac Surg 2007;32:422-30.
Rocco G. Intraoperative measures for preventing residual air spaces. Thorac Surg Clin 2010;20:371-5.
Burt BM, Shrager JB. Prevention and management of postoperative air leaks. Ann Cardiothorac Surg 2014;3:216-8.
Kovitz KL, French KD. Endobronchial valve placement and balloon occlusion for persistent air leak: procedure overview and new current procedural terminology codes for 2013. Chest 2013;144:661-5.
Anthony VB, Hadley KJ, Sahn SA. Mechanism of pleural fibrosis in empyema. Chest 1989;95:230S–1S.
Mandal AK, Thadepalli H, Mandal AK, Chettipally U. Outcome of primary empyema thoracis: therapeutic and microbiologic aspects. Ann Thorac Surg 1998;66:1782–6.
Copyright (c) 2021 The Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
